Clinical and echocardiographic characteristics in patients with heart failure and type 2 diabetes

Mikel Jordhani1, Joana Seiti2, Vivencio Barrios3

  • 1Internal Medicine Department, Korça Regional Hospital, Korçë, 7001, Albania.

Future Cardiology
|May 4, 2022
PubMed

Insights

Type 2 diabetes (T2D) is linked to more severe heart failure (HF) and cardiac changes. Poor diabetes control worsens cardiovascular outcomes in HF patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Internal Medicine

Background:

  • Type 2 diabetes (T2D) and heart failure (HF) frequently coexist, complicating cardiovascular diagnosis and management.
  • Understanding the interplay between T2D and HF is crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the association between T2D and the clinical and echocardiographic features of patients diagnosed with HF.
  • To investigate how T2D impacts cardiac structure and function in HF patients.

Main Methods:

  • A case-control study involving 121 patients with HF.
  • Patients were categorized into two groups: those with T2D and those without.
  • Echocardiographic assessments were performed, and patients with T2D were further analyzed based on HbA1c control.

Main Results:

  • Significant differences were observed between T2D and non-T2D groups in left atrial diameter, E/E' ratio, and left ventricular end-diastolic diameter.
  • Among patients with T2D, poor glycemic control (indicated by HbA1c) correlated with increased acute HF episodes, reduced left ventricular ejection fraction, and altered left atrial diameter and E/E' ratio.

Conclusions:

  • T2D is associated with significant cardiac alterations and contributes to more severe heart failure.
  • Suboptimal diabetes management in HF patients leads to poorer cardiovascular outcomes.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
76
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
52
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
65
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
39
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
95